Nxera Pharma Dividends and Buybacks
Dividend criteria checks 0/6
Nxera Pharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-9.8%
Buyback Yield
| Total Shareholder Yield | -9.8% |
| Future Dividend Yield | 0.6% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Nxera Pharma Co., Ltd. (TSE:4565) Stocks Pounded By 25% But Not Lagging Industry On Growth Or Pricing
Sep 25
Nxera Pharma Co., Ltd.'s (TSE:4565) P/S Still Appears To Be Reasonable
Jun 26Is Nxera Pharma (TSE:4565) A Risky Investment?
Apr 06Sosei Group Corporation (TSE:4565) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable
Mar 08Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 4565's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 4565's dividend payments have been increasing.
Dividend Yield vs Market
| Nxera Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4565) | n/a |
| Market Bottom 25% (JP) | 1.8% |
| Market Top 25% (JP) | 3.8% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (4565) (up to 3 years) | 0.6% |
Notable Dividend: Unable to evaluate 4565's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 4565's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 4565's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 4565 has not reported any payouts.